Prescription Drug and Health Care Spending
Notice of proposed rulemaking.
CFR Part: "26 CFR Part 54"
RIN Number: "RIN 1545-BQ27"
Citation: "86 FR 66495"
Document Number: "REG-117575-21"
Page Number: "66495"
"Proposed Rules"
Agency: "
SUMMARY: Elsewhere in this issue of the
DATES: To be assured consideration, comments must be received at one of the addresses provided below, no later than
ADDRESSES: In commenting, please refer to file code REG-117575-21. Comments, including mass comment submissions, must be submitted in one of the following three ways (please choose only one of the ways listed):
1. Electronically. You may submit electronic comments on this regulation to http://www.regulations.gov. Follow the "Submit a comment" instructions.
2. By regular mail. You may mail written comments to the following address ONLY:
Please allow sufficient time for mailed comments to be received before the close of the comment period.
3. By express or overnight mail. You may send written comments to the following address ONLY:
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION: Inspection of Public Comments: All comments received before the close of the comment period are available for viewing by the public, including any personally identifiable or confidential business information that is included in a comment. All comments received are posted before the close of the comment period on the following website as soon as possible after they have been received: http://regulations.gov. Follow the search instructions on that website to view public comments.
Proposed Applicability Date: These regulations are generally proposed to apply on and after
Background and Regulatory Impact Analysis
The temporary regulations published elsewhere in this issue of the
Regulatory Flexibility Act
The Regulatory Flexibility Act (5 U.S.C.
Pursuant to section 7805(f), this notice of proposed rulemaking has been submitted to the Chief Counsel of Advocacy of the
1. Need for and Objectives of the Rule
The proposed regulations will implement a reporting requirement for prescription drug costs and other medical expenses. Specifically, group health plans and health insurance issuers will submit key data, which the Departments will use to report and better understand prescription drug pricing trends and their impact on consumers' premiums and out-of-pocket costs. The reporting requirements apply beginning with the data for the 2020 calendar year. This will allow the Departments to better understand national prescription drug costs and identify major drivers of increases in health care spending, which may aid in examining variation of health care costs across the country.
2. Affected Small Entities
FOOTNOTE 1 US Small Bus. Admin., 2020 Small Business Profile, https://cdn.advocacy.sba.gov/wp-content/uploads/2020/06/04144214/2020-Small-Business-Economic-Profile-States-Territories.pdf. END FOOTNOTE
Because small entities may comply with the requirements under the proposed regulations in different ways, it is difficult to estimate at this time the impact of these proposed regulations, if any, on small businesses. Small entities might, for example, enter into contracts with other entities in order to meet the requirements in the proposed regulations. Due to the lack of knowledge regarding what small entities may decide to do in order to satisfy the requirements and any costs they might incur related to contracts, the Departments seek comment on ways that the proposed regulations will impose additional costs and burdens on small entities and how many would be likely engage in contracts to meet the requirements.
3. Impact of the Regulations
The proposed regulations require group health plans and health insurance issuers in the group and individual markets to submit certain information about prescription drugs and health care spending to the Departments. The public reports that are required by the proposed regulations could enhance national health transparency and lower prescription drug and health care costs. Consumers could potentially benefit from the required reporting if plans and issuers are able to negotiate lower prescription drug prices and those reductions are passed on to the consumer in the form of reduced out-of-pocket costs and lower premiums. The public reports that are required by the proposed regulations will create certain compliance burdens. The recordkeeping and reporting requirements will increase for plans and issuers subject to the regulations. This includes costs associated with developing, building, and maintaining information technology systems necessary to report the required data. The maintenance costs for these information technology systems may decrease in succeeding years as plans and issuers (or third parties on their behalf) gain efficiencies and experience in updating, managing, and submitting the required data. Although the
4. Alternatives Considered
As described in more detail in the Regulatory Impact Analysis of the preamble to the temporary regulations, published elsewhere in this issue of the
5. Duplicative, Overlapping, or Conflicting Federal Rules
As explained in the preamble to the temporary regulations, published elsewhere in this issue of the
Drafting Information
The principal author of this notice of proposed rulemaking is
List of Subjects in 26 CFR Part 54 Excise taxes, Pensions, Reporting and recordkeeping requirements.
Proposed Amendments to the Regulations
Accordingly, 26 CFR part 54 is proposed to be amended as follows:
PART 54--PENSION EXCISE TAXES Paragraph. 3. The authority citation for part 54 continues to read as follows:
Authority: 26 U.S.C. 7805
Par. 4. Sections 54.9825-1 through 6 are added to read as follows:
[The text of proposed
[The text of proposed
[The text of proposed
[The text of proposed
[The text of proposed
[The text of proposed
Deputy Commissioner for Services and Enforcement.
[FR Doc. 2021-25202 Filed 11-17-21;
BILLING CODE 4630-01-P


Speed Bumps Aren’t Likely To Stop Powell’s Fed Nomination
Nationwide Survey: Perspectives On Anxiety Between Parents, Young Adults
Advisor News
- Dutch gambling tax hike falls short as prediction markets eye World Cup
- Caregiving: A challenge that costs employers billions
- Could your practice benefit from an advisory board?
- SEC nears settlement with accused scammer Tai Lopez
- The 3 things that shrink your Social Security income
More Advisor NewsAnnuity News
- Globe Life Inc. (NYSE: GL) Highlighted for Surprising Price Action
- Trademark Application for “EMPOWER YOUR MONEY” Filed by Empower Annuity Insurance Company of America: Empower Annuity Insurance Company of America
- Built-in guaranteed annuities: What advisors should know
- Malibu Life Holdings Completes Acquisition of TruSpire, Establishing Malibu USA and Accelerating Entry into the U.S. Retail Annuity Market
- Why job boards are failing insurance agencies
More Annuity NewsHealth/Employee Benefits News
- Public worker premiums to spike again
NJ public worker health plans poised for another year of premium hikes
- New Health and Medicine Findings Has Been Reported by Researchers at Health Insurance Review and Assessment Service (Mortality, Health Care Use, and Spending Patterns During South Korea’s Trainee Physicians’ Walkout): Health and Medicine
- Dishonest telemarketers are selling fake health insurance, leaving Minnesotans in the lurch
- NC’s State Health Plan switching who administers its members’ benefits, again
- Caregiving: A challenge that costs employers billions
More Health/Employee Benefits NewsLife Insurance News
- Could your practice benefit from an advisory board?
- AM Best Revises Outlooks to Stable for Missouri Farm Bureau Group’s Members and Farm Bureau Life Insurance Company of Missouri
- Globe Life Inc. (NYSE: GL) Highlighted for Surprising Price Action
- AM Best Assigns Credit Ratings to China Ping An Insurance (Hong Kong) Company Limited
- Reliance Matrix Expands Employee Navigator Integration with New Evidence of Insurability (EOI) API Enhancement
More Life Insurance News